In patients with locally advanced disease, positive LOXL2 expression was highly correlated with tumor T stage and lymph node metastasis, suggesting that LOXL2 may promote the progression of ESCC through its involvement in tumor proliferation and metastasis. Here, LOXL2 is linked to neoplasm.